84 related articles for article (PubMed ID: 32533406)
1. Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients.
Ditsch N; Heublein S; Jeschke U; Sattler C; Kuhn C; Hester A; Czogalla B; Trillsch F; Mahner S; Engel J; Mayr D; Schmoeckel E
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1923-1932. PubMed ID: 32533406
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone receptor α1 acts as a new squamous cell lung cancer diagnostic marker and poor prognosis predictor.
Mohamed FEZA; Abdelaziz AO; Kasem AH; Ellethy T; Gayyed MF
Sci Rep; 2021 Apr; 11(1):7944. PubMed ID: 33846395
[TBL] [Abstract][Full Text] [Related]
3. In Vivo and Ex Vivo Analysis of Omental Adhesion in Ovarian Cancer.
Harper EI; Hilliard TS
Methods Mol Biol; 2022; 2424():199-216. PubMed ID: 34918297
[TBL] [Abstract][Full Text] [Related]
4. A multiomics comparison between endometrial cancer and serous ovarian cancer.
Zhong H; Chen H; Qiu H; Huang C; Wu Z
PeerJ; 2020; 8():e8347. PubMed ID: 31942259
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of the Coiled-Coil Domain Containing 80 and Its Perspective Mechanisms in Ovarian Carcinoma: A Comprehensive Study.
Liang ZQ; Gao L; Chen JH; Dai WB; Su YS; Chen G
Int J Genomics; 2021; 2021():3752871. PubMed ID: 34820451
[TBL] [Abstract][Full Text] [Related]
6. Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer.
Czogalla B; Partenheimer A; Badmann S; Schmoeckel E; Mayr D; Kolben T; Beyer S; Hester A; Burges A; Mahner S; Jeschke U; Trillsch F
Transl Oncol; 2021 Jan; 14(1):100910. PubMed ID: 33069100
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic VDR expression as an independent risk factor for ovarian cancer.
Czogalla B; Deuster E; Liao Y; Mayr D; Schmoeckel E; Sattler C; Kolben T; Hester A; Fürst S; Burges A; Mahner S; Jeschke U; Trillsch F
Histochem Cell Biol; 2020 Oct; 154(4):421-429. PubMed ID: 32572587
[TBL] [Abstract][Full Text] [Related]
8. The decidual expression of Interleukin-7 is upregulated in early pregnancy loss.
Vilsmaier T; Amann N; Löb S; Schmoeckel E; Kuhn C; Zati Zehni A; Meister S; Beyer S; Kolben TM; Becker J; Mumm JN; Mahner S; Jeschke U; Kolben T
Am J Reprod Immunol; 2021 Sep; 86(3):e13437. PubMed ID: 33934432
[TBL] [Abstract][Full Text] [Related]
9. Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs).
Lin L; Kuhn C; Ditsch N; Kolben T; Czogalla B; Beyer S; Trillsch F; Schmoeckel E; Mayr D; Mahner S; Jeschke U; Hester A
Breast Cancer Res; 2021 Apr; 23(1):45. PubMed ID: 33849622
[TBL] [Abstract][Full Text] [Related]
10. Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group.
Trillsch F; Mahner S; Czogalla B; Rottmann M; Chekerov R; Braicu EI; Oskay-Öczelik G; Wimberger P; Richter R; Sehouli J
J Gynecol Oncol; 2021 May; 32(3):e37. PubMed ID: 33825355
[TBL] [Abstract][Full Text] [Related]
11. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
Cells; 2021 Mar; 10(3):. PubMed ID: 33799631
[TBL] [Abstract][Full Text] [Related]
12. Mutations in
Fasching PA; Yadav S; Hu C; Wunderle M; Häberle L; Hart SN; Rübner M; Polley EC; Lee KY; Gnanaolivu RD; Hadji P; Hübner H; Tesch H; Ettl J; Overkamp F; Lux MP; Ekici AB; Volz B; Uhrig S; Lüftner D; Wallwiener M; Müller V; Belleville E; Untch M; Kolberg HC; Beckmann MW; Reis A; Hartmann A; Janni W; Wimberger P; Taran FA; Fehm TN; Wallwiener D; Brucker SY; Schneeweiss A; Hartkopf AD; Couch FJ
J Clin Oncol; 2021 May; 39(15):1619-1630. PubMed ID: 33780288
[TBL] [Abstract][Full Text] [Related]
13. Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials.
Villegas SL; Nekljudova V; Pfarr N; Engel J; Untch M; Schrodi S; Holms F; Ulmer HU; Fasching PA; Weber KE; Albig C; Heinrichs C; Marmé F; Hartmann A; Hanusch C; Schmitt WD; Huober J; Lederer B; van Mackelenbergh M; Tesch H; Jackisch C; Rezai M; Sinn P; Sinn BV; Hackmann J; Kiechle M; Schneeweiss A; Weichert W; Denkert C; Loibl S
Eur J Cancer; 2021 May; 148():159-170. PubMed ID: 33743484
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer.
Zehni AZ; Batz F; Vattai A; Kaltofen T; Schrader S; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478016
[TBL] [Abstract][Full Text] [Related]
15. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020.
Ditsch N; Untch M; Kolberg-Liedtke C; Jackisch C; Krug D; Friedrich M; Janni W; Müller V; Albert US; Banys-Paluchowski M; Bauerfeind I; Blohmer JU; Budach W; Dall P; Diel I; Fallenberg EM; Fasching PA; Fehm T; Gerber B; Gluz O; Hanf V; Harbeck N; Heil J; Huober J; Kreipe HH; Kühn T; Kümmel S; Loibl S; Lüftner D; Lux M; Maass N; Moebus V; Mundhenke C; Park-Simon TW; Reimer T; Rhiem K; Rody A; Schmidt M; Schneeweiss A; Solbach C; Solomayer EF; Stickeler E; Thomssen C; Witzel I; Wöckel A; Thill M
Breast Care (Basel); 2020 Jun; 15(3):294-309. PubMed ID: 32774225
[No Abstract] [Full Text] [Related]
16. Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways.
Schneider M; Köpke MB; Zehni AZ; Vilsmaier T; Kessler M; Kailuweit M; Vattai A; Heidegger HH; Cavaillès V; Jeschke U; Ditsch N
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509273
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Relevance of Nuclear Receptors in Relation to Peritumoral Inflammation and Tumor Infiltration by Lymphocytes in Breast Cancer.
Köpke MB; Chateau MC; Boissière-Michot F; Schneider M; Garrido F; Zati-Zehni A; Vilsmaier T; Kessler M; Ditsch N; Cavaillès V; Jeschke U
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230483
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic Colocalization of RXRα and PPARγ as an Independent Negative Prognosticator for Breast Cancer Patients.
Shao W; Köpke MB; Vilsmaier T; Zati Zehni A; Kessler M; Sixou S; Schneider M; Ditsch N; Cavaillès V; Jeschke U
Cells; 2022 Apr; 11(7):. PubMed ID: 35406808
[TBL] [Abstract][Full Text] [Related]
19. Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian Cancer.
Heublein S; Jeschke U; Sattler C; Kuhn C; Hester A; Czogalla B; Trillsch F; Mahner S; Mayr D; Schmoeckel E; Ditsch N
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269838
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
